Ex­clu­sive: Sidu­ma, a biotech from Arv­inas' sci­en­tif­ic founder, shut­ters due to 'fi­nanc­ing en­vi­ron­men­t'

Sidu­ma Ther­a­peu­tics, a Yale spin­out from Arv­inas sci­en­tif­ic founder Craig Crews, has closed, a spokesper­son for the com­pa­ny con­firmed to End­points News via email Thurs­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.